[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Pompe Disease Drug Market Research Report Forecast 2017-2021

June 2017 | 135 pages | ID: UB2C33DA8DEEN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Pompe Disease Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Pompe Disease Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pompe Disease Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Genzyme(a Sanofi company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
company 8
company 9

United States Pompe Disease Drug Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
United States Pompe Disease Drug Market: Application Segment Analysis
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 POMPE DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Pompe Disease Drug
1.2 Pompe Disease Drug Market Segmentation by Type
  1.2.1 United States Production Market Share of Pompe Disease Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Pompe Disease Drug Market Segmentation by Application
  1.3.1 Pompe Disease Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pompe Disease Drug (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON POMPE DISEASE DRUG INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES POMPE DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 United States Pompe Disease Drug Production and Share by Manufacturers (2015 and 2016)
3.2 United States Pompe Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Pompe Disease Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Pompe Disease Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Pompe Disease Drug Market Competitive Situation and Trends
  3.5.1 Pompe Disease Drug Market Concentration Rate
  3.5.2 Pompe Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES POMPE DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Pompe Disease Drug Production and Market Share by Type (2012-2017)
4.2 United States Pompe Disease Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Pompe Disease Drug Price by Type (2012-2017)
4.4 United States Pompe Disease Drug Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES POMPE DISEASE DRUG MARKET ANALYSIS BY APPLICATION

5.1 United States Pompe Disease Drug Consumption and Market Share by Application (2012-2017)
5.2 United States Pompe Disease Drug Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES POMPE DISEASE DRUG MANUFACTURERS ANALYSIS

6.1 Genzyme?a Sanofi company)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 BioMarin
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Amicus
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Audentes
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 EpiVax
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Oxyrane
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Sangamo
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 company
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 POMPE DISEASE DRUG MANUFACTURING COST ANALYSIS

7.1 Pompe Disease Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pompe Disease Drug

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pompe Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pompe Disease Drug Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES POMPE DISEASE DRUG MARKET FORECAST (2017-2021)

11.1 United States Pompe Disease Drug Production, Revenue Forecast (2017-2021)
11.2 United States Pompe Disease Drug Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Pompe Disease Drug Production Forecast by Type (2017-2021)
11.4 United States Pompe Disease Drug Consumption Forecast by Application (2017-2021)
11.5 Pompe Disease Drug Price Forecast (2017-2021)

CHAPTER 12 APPENDIX



LIST OF TABLES AND FIGURES

Figure Picture of Pompe Disease Drug
Table Classification of Pompe Disease Drug
Figure United States Sales Market Share of Pompe Disease Drug by Type in 2015
Table Application of Pompe Disease Drug
Figure United States Sales Market Share of Pompe Disease Drug by Application in 2015
Figure United States Pompe Disease Drug Sales and Growth Rate (2011-2021)
Figure United States Pompe Disease Drug Revenue and Growth Rate (2011-2021)
Table United States Pompe Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Pompe Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pompe Disease Drug Sales Share by Manufacturers
Figure 2016 Pompe Disease Drug Sales Share by Manufacturers
Table United States Pompe Disease Drug Revenue by Manufacturers (2015 and 2016)
Table United States Pompe Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pompe Disease Drug Revenue Share by Manufacturers
Table 2016 United States Pompe Disease Drug Revenue Share by Manufacturers
Table United States Market Pompe Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pompe Disease Drug Average Price of Key Manufacturers in 2015
Figure Pompe Disease Drug Market Share of Top 3 Manufacturers
Figure Pompe Disease Drug Market Share of Top 5 Manufacturers
Table United States Pompe Disease Drug Sales by Type (2012-2017)
Table United States Pompe Disease Drug Sales Share by Type (2012-2017)
Figure United States Pompe Disease Drug Sales Market Share by Type in 2015
Table United States Pompe Disease Drug Revenue and Market Share by Type (2012-2017)
Table United States Pompe Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pompe Disease Drug by Type (2012-2017)
Table United States Pompe Disease Drug Price by Type (2012-2017)
Figure United States Pompe Disease Drug Sales Growth Rate by Type (2012-2017)
Table United States Pompe Disease Drug Sales by Application (2012-2017)
Table United States Pompe Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Pompe Disease Drug Sales Market Share by Application in 2015
Table United States Pompe Disease Drug Sales Growth Rate by Application (2012-2017)
Figure United States Pompe Disease Drug Sales Growth Rate by Application (2012-2017)
Table Genzyme?a Sanofi company) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genzyme?a Sanofi company) Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Genzyme?a Sanofi company) Pompe Disease Drug Market Share (2012-2017)
Table BioMarin Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BioMarin Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table BioMarin Pompe Disease Drug Market Share (2012-2017)
Table Amicus Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amicus Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Amicus Pompe Disease Drug Market Share (2012-2017)
Table Audentes Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Audentes Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Audentes Pompe Disease Drug Market Share (2012-2017)
Table EpiVax Basic Information, Manufacturing Base, Production Area and Its Competitors
Table EpiVax Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table EpiVax Pompe Disease Drug Market Share (2012-2017)
Table Oxyrane Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Oxyrane Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Oxyrane Pompe Disease Drug Market Share (2012-2017)
Table Sangamo Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sangamo Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Sangamo Pompe Disease Drug Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Pompe Disease Drug Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Pompe Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Pompe Disease Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pompe Disease Drug
Figure Manufacturing Process Analysis of Pompe Disease Drug
Figure Pompe Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Pompe Disease Drug Major Manufacturers in 2015
Table Major Buyers of Pompe Disease Drug
Table Distributors/Traders List
Figure United States Pompe Disease Drug Production and Growth Rate Forecast (2017-2021)
Figure United States Pompe Disease Drug Revenue and Growth Rate Forecast (2017-2021)
Table United States Pompe Disease Drug Production Forecast by Type (2017-2021)
Table United States Pompe Disease Drug Consumption Forecast by Application (2017-2021)


More Publications